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Abstract An economic and cheap production of large
amounts of recombinant allergenic proteins might become
a prerequisite for the common use of microarray-based
diagnostic allergy assays which allow a component-speciﬁc
diagnosis. A molecular pharming strategy was applied to
express the major allergen of Artemisia vulgaris pollen, Art
v 1, in tobacco plants and tobacco cell cultures. The ori-
ginal Art v 1 with its endogenous signal peptide which
directs Art v 1 to the secretory pathway, was expressed in
transiently transformed tobacco leaves but was lost in
stable transformed tobacco plants during the alternation of
generations. Using a light-regulated promoter and ‘‘hiding’’
the recombinant Art v 1 in the ER succeeded in expression
of Art v 1 over three generations of tobacco plants and in
cell cultures generated from stable transformed plants.
However, the amounts of the recombinant allergen were
sufﬁcient for analysis but not high enough to allow an
economic production. Although molecular pharming has
been shown to work well for the production of non-plant
therapeutic proteins, it might be less efﬁcient for closely
related plant proteins.
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Introduction
Type I allergy, a hypersensitivity disease that is charac-
terised by the production of IgE antibodies against the
allergen (antigen), is now affecting more than 25% of the
European population (Schmidt et al. 2008; Valenta et al.
2010) thus demanding new diagnostic and therapeutic
tools. So far, native allergen extracts from allergen sources,
e.g. pollen grains, cat dander and house dust mites, are used
for diagnosis and also during speciﬁc immunotherapy (see
Valenta et al. 2010 and references therein for general
aspects of allergy and allergy treatments). Diagnostic tests
using extracts allow the identiﬁcation of the allergen-con-
taining source whereas the application of puriﬁed allergens
can identify the allergy-eliciting molecules (Cromwell
et al. 2004; Valenta and Kraft 2002; Valenta et al. 1999).
To improve diagnostic assays, the use of puriﬁed allergens
is necessary (van Ree et al. 2008) but the puriﬁcation of
allergenic proteins from natural allergen sources is difﬁcult
as minute contaminations with other allergens cannot be
excluded, and is far too expensive making their application
in clinical diagnosis almost impossible. During the last
25 years, more and more allergens were identiﬁed by
molecular biology techniques and recombinant allergens
were produced in prokaryotic expression systems resem-
bling most of the molecular properties of the native
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DOI 10.1007/s00299-011-1199-3allergens including their IgE-binding capacity (Wallner
et al. 2004). However, the majority of allergenic proteins
are of plant origin and the prokaryotic expression systems
fail to mimic plant-speciﬁc post-translational modiﬁcations
identiﬁed in a number of major plant-derived allergens.
Molecular pharming is the production of important
pharmaceutical and commercially valuable proteins in
plants or plant cell cultures, and may become a common
procedure to produce large amounts of recombinant aller-
gens on a cost-effective base (Daniell et al. 2001, 2009;
Hellwig et al. 2004; Horn et al. 2004; Obermeyer et al.
2004). Compared to animal or microbial expression sys-
tems, the plant-based expression has several advantages:
potential for large-scale and low-cost biomass production,
low risk of contaminants (mammalian viruses, prions,
oncogenes or bacterial toxins), correct folding, post-trans-
lational modiﬁcations and assembly of multimeric proteins,
low downstream processing costs, simultaneous production
of multiple proteins and ﬁnally, less ethical problems than
with transgenic animals and thus higher acceptance in the
public (Doran 2000). Depending on the expressed protein
and the plant system used for production up to 0.5 mg
recombinant protein per gram plant tissue could be pro-
duced at very low costs (\100 US $ g
-1 protein, Daniell
et al. 2001). In addition, some plant-speciﬁc post-transla-
tional modiﬁcations, e.g. O-glycosylation which cannot be
produced by bacteria or yeasts, have been suggested to be
important for allergen recognition (Leonard et al. 2005),
and therefore, plants are the expression system of choice
for such modiﬁed proteins.
In the last few years, the suitability of recombinant
allergens for clinical diagnostic assays has been investi-
gated in vivo and in vitro (Astier et al. 2006; Schmid-
Grendelmeier et al. 2003). Recombinant allergens were
also spotted onto microarray carriers, which allow a com-
ponent-speciﬁc diagnosis instead of the usual identiﬁcation
of the allergen source (Deinhofer et al. 2004; Hiller et al.
2002; Kim et al. 2002; Vigh-Conrad et al. 2010). These
allergen microarrays allow a fast and speciﬁc allergen
diagnosis at the molecular level. However, the production
costs of these microarray-based assays will ﬁnally decide
whether the clinical diagnosis of allergies will be per-
formed with conventional extracts or with recombinant
allergens. Recombinant allergens produced by molecular
pharming techniques will help to dramatically reduce the
production costs for allergen assays thus enabling these
future perspectives in allergy diagnosis and may also be
applicable for next generation allergy therapy.
To test the suitability of the plant-based production of
allergens, we selected the major allergen of mugwort
(Artemisia vulgaris), Art v 1, as a candidate for molecular
pharming because earlier studies reported a lower IgE
recognition of recombinant Art v 1 produced in E. coli
probably due to post-translational glycosylation of the
Art v 1 molecule (Himly et al. 2003; Schmid-Grendelmeier
et al. 2003). Art v 1 is a 108 amino acid-long protein
(apparent molecular weight in gel electrophoresis between
20 and 27 kDa) of unknown function with a cysteine-rich
defensin-like domain at the N-terminus and a C-terminal
proline-rich domain (Himly et al. 2003; Razzera et al.
2010). In addition, an N-terminal signal peptide predicts
that Art v 1 enters the secretory pathway and is secreted
into the external medium or cell wall of mugwort pollen.
Two types of post-translational modiﬁcations were detec-
ted: hydroxylation of proline residues and a new type of an
O-glycan composed of galactoses and arabinoses that were
suggested to be important for the formation of IgE binding
epitopes (Leonard et al. 2005). Using a molecular pharm-
ing strategy to produce sufﬁcient amounts of recombinant
Art v 1 might be applied to other allergens thus enhancing
the quality of recombinant allergens and contemporaneously
reducing production costs.
Materials and methods
Plant growth conditions
Wild-type tobacco plants (Nicotiana tabacum cv. SR1)
were grown in a greenhouse under environmental condi-
tions with artiﬁcial light (16 h light/8 h dark). Plants were
fertilised weekly with commercial fertiliser. Surface ster-
ilised seeds of transformed tobacco plants were cultivated
on standard Murashige and Skoog (MS-) salts medium
plus B5 vitamins, 3% (w/v) sucrose, 0.8% (w/v) agar,
100 mg l
-1 kanamycin under aseptic conditions in growth
chambers (16 h light/8 h dark, 24C, Percival Scientiﬁc,
model I-66HILQ, Perry, IA, USA) and ﬁnally transferred
to soil, grown for 16 h light, 24C and 8 h dark, 19C
(GroBanks, CLF, Emmersacker, Germany).
Construction of plasmids for plant expression
The plasmid pBI121-Artv1 was constructed by inserting
the full-length Art v 1 coding sequence including its
endogenous signal peptide (SPArtv1) between the BamHI
and SstI cleavage sites of pBI121 (Fig. 1, Chen et al. 2003,
access. no. AF485783), thus placing the Art v 1 coding
sequence under the control of the CaMV 35S promoter and
replacing the previous b-glucuronidase sequence. In addi-
tion, the Art v 1 signal peptide was fused to a GFP
sequence using standard cloning and SOE (splicing by
overlapping ends)-PCR (Horton et al. 1983) techniques and
cloned into pBI121 between BamHI and SstI (Fig. 1).
Vectors of the pIMPACT series were obtained from Plant
Research International (Wageningen, The Netherlands
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123(http://www.impactvector.com)). The sequence of Art v 1
without its endogenous signal peptide was inserted between
the NcoI and BglII cleavage sites of pIMPACT 1.3
resulting in Art v 1 fused to a sea anemone signal peptide
(SPsea) at the N-terminus (Outchkourov et al. 2003), a
6xHis tag and a c-myc tag at the C-terminus followed by a
KDEL signal under the control of the chrysanthemum
promoter rbcS1 (Outchkourov et al. 2003) resulting in
pIMPACT-Artv1
ER (Fig. 1, Fig. S1). In addition, a GFP
coding sequence was also cloned into the respective pIM-
PACT vectors resulting in pIMPACT-GFP
ER which served
as a control vector. The constructed expression cassettes,
e.g. rbcS1 promoter-SPsea::Artv1::6xHis::c-myc::KDEL-
rbcS1 terminator, were subcloned into pBINPLUS (van
Engelen et al. 1995) by cutting both vectors with AscI and
PacI. Digestion products were puriﬁed by agarose gel
electrophoresis and ligated into BINPLUS giving the fol-
lowing vectors for plant transformation: pBINPLUS/pIm-
pact-Artv1
ER and pBINPLUS/pImpact-GFP
ER (Fig. 1).
All cloning steps were monitored by control PCRs using
combinations of primer pairs hybridizing to vector and
insert sequences, respectively, and sequencing of the insert
with its ﬂanking regions. All vectors resulting from the
various cloning steps were incorporated into E. coli (DH5a)
for ampliﬁcation, controlling, and storage. The incorpora-
tion of the Art v 1 sequence into the tobacco genome
(Fig. 3) was detected by PCR with the forward primer
50-ATGACGCACAATCCCACTATC-30 and the reverse
primer 50-TCTACAGCAGCAGATCCA-30 using 1 U of
AmpliTaq DNA polymerase (Agilent Technologies, Santa
Clara, CA, USA), 50C annealing temperature and 35
cycles. Generally, standard molecular biology methods
described by Sambrook et al. (2001)w e r ep e r f o r m e dw i t h
some adaptations for recombinant allergen expression
described by Obermeyer et al. (2004).
Growth and transformation of Agrobacteria
Agrobacterium tumefaciens (LBA 4404, Life Technolo-
gies, Rockville, USA) were grown in YM medium [0.04%
(w/v) yeast extract, 1% (w/v) mannitol, 1.7 mM NaCl,
0.8 mM MgSO4, 2.2 mM K2PO4, pH 7.0 adjusted with
NaOH] supplemented with 100 mg l
-1 streptomycin and
transformed with the appropriate pBINPLUS constructs by
Fig. 1 Plasmid constructs used for the expression of Art v 1 in plants.
Plasmids derived from pBI121: the entire ORF of Art v 1 including
the endogenous signal peptide was placed between the restriction sites
BamHI and SstI under the control of the 35S cauliﬂower mosaic
promoter (P35S). Alternatively, the Art v 1 signal peptide was fused
to the N-terminus of GFP (pBI121_SpArtv1::GFP), also under control
of P35S. RB right border, LB left border, TNOS terminator of nopaline
synthase, PNOS promoter of nopaline synthase, NPT II kanamycin
resistance gene. Plasmids derived from pBINPLUS and pIMPACT
series: coding sequence of Art v 1 without the signal peptide was
cloned between NcoI and BglII sites in pIMPACT 1.3 resulting in an
ER-localised protein. Expression is under control of the chrysanthe-
mum promoter rbcS1 (PRbcS1). A signal peptide from sea anemona
(SPsea) directs the protein of interest to the secretory pathway and the
KDEL peptide retains the protein in the ER. All proteins are
expressed with a C-terminal c-myc tag and 6xHis tag
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123electroporation (GenePulser, Biorad, Vienna, Austria) as
described by Obermeyer et al. (2004). Transformed Agro-
bacteriawereselectedonYMmediumcontaining100 mg l
-1
kanamycin.
Transformation and regeneration of tobacco plants
Prior to plant transformation, Agrobacteria were grown in
YM medium with the appropriate antibiotics plus 10 mM
MES, pH 5.6 and 200 lM acetosyringone to an OD600 of
0.6–0.8. Agrobacteria were pelleted at 4,0009g (20 min,
15C) and resuspended in inﬁltration medium [MS-salts,
2% (w/v) sucrose, 200 lM acetosyringone, pH 5.8 adjusted
with NaOH]. For transient expression, tobacco leaves from
young plants (8 to 12-leaves) were vacuum-inﬁltrated with
the Agrobacterium suspension (Kapila et al. 1997)o r
Agrobacteria suspension was injected into the intercellular
space of leaves still connected to the plant via a syringe
pressed gently at the lower leaf side. For stable expression, a
leaf disc transformation protocol was followed (Horsch et al.
1985;Obermeyeretal.2004).Inbrief,discscutfromsurface-
sterilised tobacco leaves, were co-cultivated with Agrobac-
teriumculturesfor3 daysinthelightat24CinasealedPetri
dish on MS-agar. Leaf discs were washed with MS-medium
plus 100 lgm l
-1 timentin and cultivated on MS-agar,
100 mg l
-1 timentin, 100 mg l
-1 kanamycin, 0.1 mg l
-1
a-naphthalene acetic acid (aNAA), 1 mg l
-1 benzyl adenine
(BA)at24Cinagrowthchamber(16 hlight/8 hdark).After
4 weeks green shoots (approximately 10–15 mm) were
transferred to solid MS-medium without hormones in
Magentaboxes(Sigma,Vienna,Austria)andcultivatedunder
thesame conditions.Afterdevelopmentofroots,theplantlets
were transferred to soil and further cultivated for analysis.
Induction and maintenance of transgenic tobacco cell
cultures
Leaf discs from wild type and transgenic tobacco plants
growing under aseptic conditions, were cultivated on
MS-medium supplemented with B5 vitamins and 1 mg l
-1
2,4-dichlorophenoxy acetic acid (2,4-D) without (wild-type)
or with 100 mg l
-1 kanamycin (transformants) in the dark
at 28C to induce callus growth. Generation of pale yellow,
friable calli was inspected weekly. After 4 weeks, calli
were isolated and sub-cultivated for another 4 weeks
before they were divided for propagation (24 h dark,
28C). To generate cell suspension cultures, callus material
(ca. 1–2 g) was gently cut into small pieces and transferred
to liquid medium (same composition as above without
agar) and incubated at 24C and 100 rpm in an incubation
shaker. Clones from the same calli or cell suspension
cultures were cultivated in parallel in the dark or at day/
night cycles of 16 h/8 h at 24C.
Protoplast preparation and ﬂuorescence microscopy
Wild-type and transgenic tobacco leaves (GFP expression)
were cut into small pieces and inﬁltrated with 5 ml pro-
toplast isolation medium (500 mM mannitol, 10 mM KCl,
10 mM CaCl2, 10 mM MES adjusted to pH 5.7 with Tris).
Inﬁltrated leaf pieces were incubated in protoplast isolation
medium plus 1% cellulase (Duchefa, Haarlem, The Neth-
erlands) and 0.02% pectinase (Sigma) for 2 h at room
temperature (RT) with another hour at RT under gentle
shaking at 50 rpm. Protoplasts were washed twice with
protoplast isolation medium. Protoplasts were inspected for
GFP ﬂuorescence using an epiﬂuorescence microscope
(Zeiss Axiovert 135, Oberkochen, Germany) equipped
with a video camera (SPOT Insight, Visitron, Puchheim,
Germany) with ﬁlter settings for GFP ﬂuorescence (ex, 470
± 20 nm; dichroic mirror, 495 nm; em, 525 ± 25 nm,
AHF, Tu ¨bingen, Germany) or by confocal laser-scanning
microscopy (Zeiss LSM 510).
Preparation of pollen exudates, leaf lysates,
and intercellular ﬂuids
Pollen exudates were prepared according to Hoidn et al.
(2005). Cell lysates were prepared by freezing leaf or
callus pieces in liquid nitrogen and grinding to a ﬁne
powder which was transferred into an equal volume of ice
cold lysis buffer containing 100 mM sodium phosphate,
pH 7.0, 150 mM NaCl, 2 mM ethylene glycol-bis(ß-amino
ethyl ether) N,N,N0,N0-tetraacetic acid (EGTA), 2 mM
ethylenediaminetetraacetic acid (EDTA), 2 mM 1,4-dithio-
D-threitol (DTT), 0.5 mM 4-(2-amino-ethyl)benzenesulfo-
nyl ﬂuoride hydrochloride (AEBSF), 5 mg l
-1 aprotinin
and 5 mg l
-1 leupeptin, mixed well and centrifuged at
10,0009g for 15 min at 4C to remove cell debris and
larger organelles. Leaf inﬁltrates were prepared by vacuum
inﬁltration of leaves with inﬁltration buffer (100 mM
sodium phosphate buffer, pH 7.0, 100 mM NaCl). The
inﬁltrated leaves were placed in a 20 ml syringe in a 50 ml
centrifugation tube and centrifuged at 8009g for 10 min at
RT. The intercellular ﬂuid was collected at the bottom of
the centrifugation tube.
Enrichment of tagged recombinant proteins
and immunodetection
The cell lysate (1 ml) was incubated with 1 ml Ni
2?
nitriloacetic acid (Ni–NTA) agarose (Qiagen, Hilden,
Germany) or Ni
2? iminodiacetic acid (Ni-IDA, Machery-
Nagel, Du ¨ren, Germany) equilibrated with wash buffer
(50 mM sodium phosphate, pH 7.0, 300 mM NaCl, 1 M
urea) for 30 min at 4C in a disposable 2 ml column
(Biorad, Vienna, Austria). The Ni–NTA agarose beads
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123with the bound His-tagged protein were washed three times
with 1 ml wash buffer and eluted twice with 1 ml elution
buffer (50 mM sodium phosphate, pH 7.0, 300 mM NaCl,
1 M urea, 250 mM imidiazole). The protein concentration
of all fractions was determined (Bradford assay, Biorad)
and fractions were aliquoted and stored at -20C for fur-
ther analysis.
Proteins were separated by SDS-PAGE and electro-
blotted onto nitrocellulose membranes by standard meth-
ods. The membrane was blocked with 3% (w/v) casein in
PBS-Tween (phosphate-buffered saline with 0.2% Tween
20) overnight at 4C, washed three times with PBS-Tween,
incubated for 1 h at RT with primary antibody diluted in
PBS-Tween, washed three times in PBS-Tween, incubated
for 1 h at RT with secondary antibody diluted with PBS-
Tween, washed three times with PBS-Tween. Secondary
antibodies conjugated with an alkaline phosphatase (AP)
were detected in 100 mM Tris/HCl, pH 9.5, 100 mM NaCl,
50 mM MgCl2, 0.175 mg ml
-1 5-bromo-4-chloro-3-indo-
lyl-phosphate p-toluidine salt (BCIP) and 0.3375 mg ml
-1
nitroblue tetrazolium chloride (NBT) at RT. Horse radish
peroxidase (HRP)-conjugated antibodies were detected by
chemiluminescence (ECL, GE Healthcare, Vienna, Aus-
tria). Human serum IgEs were detected as described pre-
viously (Himly et al. 2003) using sera of mugwort allergic
patients with positive reactivity against the major allergen
Art v 1. The following combinations of primary and sec-
ondary antibodies were used for immunodetection:
1. anti-Artv1 (1:100, Bauer et al. 2003) and anti-mouse
IgG/IgM-AP (1:5,000, Dianova, Hamburg, Germany)
or anti-mouse IgG/IgM-HRP (1:5,000, Dianova);
2. anti-Artv1arabinose (1:40) which is a single-chain
variable fragment antibody directly conjugated with
AP (scFv-AP) and recognises the alpha-arabinose of
type III arabinogalactans which were found on Art v 1
proteins (Gruber et al. 2009);
3. anti-GFP (1:250, Clontech, Saint Germain, France)
and monoclonal anti-rabbit IgG-AP (1:8,000, Sigma)
or monoclonal anti-rabbit IgG-HRP (1:8,000, Sigma);
4. anti-His tag (1:1,000, Qiagen) and goat anti-mouse
IgG-AP (1:8,000, Sigma) or goat anti-mouse IgG-HRP
(1:5,000, Sigma);
5. anti-cmyc (1:2000, Invitrogen, Lofer, Austria) and
goat anti-mouse IgG-AP (1:8,000, Sigma) or goat anti-
mouse IgG-HRP (1:8,000, Sigma).
Results and discussion
To test whether tobacco plants are a suitable expression
system for the production of the recombinant Artemisia
vulgaris pollen allergen Art v 1, the entire coding sequence
including the endogenous signal peptide of Art v 1 (SPArtv1)
was cloned into the plant transformation vector pBI121
(pBI121_Artv1, Fig. 1). Transiently transformed tobacco
leaves expressed Art v 1 already 2 days after being infected
with Agrobacteria whereas no Art v 1-speciﬁc signals could
be observed in leaves injected with water (Fig. 2a). The Art
v 1-speciﬁc antibody recognised the typical double band
around 20 and 25 kDa which was also detectable in mug-
wort pollen exudates containing the native Art v 1. It has to
be noted that the difference between the apparent molecular
weight during SDS-PAGE (20–25 kDa) and the calculated
molecular weight of Art v 1 (10.8 kDa) is caused by dif-
ferent intrinsic folding of the proline-rich C-terminus and
various glycosylation levels (see Himly et al. (2003)a n d
Leonard et al. (2005) for detailed discussion). In addition,
both protein bands of the recombinant Art v 1 were also
detected by an antibody fragment generated against the Art
v 1-speciﬁc glycosylation pattern (single chain variable
fragment antibody (scFv-AP = anti-Artv1arabinose),
Fig. 2a). This may indicate a partial glycosylation of the
recombinant protein although only the upper band of the
native Art v 1 obtained from pollen exudates, shows a
Fig. 2 Transient expression of Art v 1 in leaves of transformed
tobacco plants. Tobacco (Nicotiana tabacum) leaves were transiently
transformed by pressure inﬁltration with Agrobacterium tumefaciens
cultures at the lower leaf site. a Art v 1-speciﬁc glycosylation and the
Art v 1 protein were detected in leaf cell lysates after 2 days in
transformed leafs (Art v 1). Water-inﬁltrated leaves (WT*IF) did not
show any signals. A pollen exudate (PE) from Artemisia vulgaris
served as a positive control. b Inﬁltrates were harvested from leaves
transformed with Agrobacteria containing the signal peptide of Art v
1 fused to GFP (SPArtv1::GFP) to verify targeting to the apoplast.
GFP-speciﬁc signals at 27 kDa were observed at 2 and 5 days after
transformation (arrow). 20 lg protein per lane, antibodies as
indicated (see ‘‘Materials and methods’’)
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123glycosylation signal. The scFv fragment recognises the
a-arabinose of type III arabinogalactans which were found
on Art v 1 proteins (Gruber et al. 2009). Recognition of two
protein bands of the recombinant Art v 1 may indicate a
partial glycosylation state of the lower band that contains
a-arabinose but still lacks the hydroxy proline O-linked b
arabinofuranosyl residues, and thus migrates faster during
gel electrophoresis (Leonard et al. 2005). A second experi-
ment, in which the signal peptide of Art v 1 was fused to the
N-terminus of GFP (pBI121_SPArtv1::GFP, Fig. 1)r e v e a l e d
that GFP is secreted. A GFP-speciﬁc signal was detected in
leaf inﬁltrates (Fig. 2b) proving the functionality of the
Art v 1 signal peptide in tobacco and its role in targeting
proteins to the secretory pathway. Note, that the lower
molecular weight bands indicate degradation of the secreted
GFP.
For in planta production of Art v 1, leaf discs were co-
cultivated with Agrobacterium tumefaciens containing
pBI121_Artv1 and tobacco plantlets were regenerated from
calli to obtain transgenic plants that permanently express
Art v 1. In a ﬁrst screen, ﬁve different plants of the T0
generation were isolated which grew on kanamycin media
and the Art v 1 sequence could be detected in their geno-
mic DNA by PCR analysis (620 bp, Fig. 3, upper panel).
Although a smaller product was also ampliﬁed from the
DNA of wild-type plants, the transformants showed a PCR
product of the same size as the control plasmid containing
the Art v 1 sequence. In addition, the Art v 1-typical double
band was recognised by an anti-Art v 1 antibody (Fig. 3,
lower panel) with low signal intensities but verifying the
presence of an Art v 1 protein in stable transformed plants
and conﬁrming a preliminary study (Gadermaier et al.
2003).
So far, the results indicated that the mugwort pollen
allergen Art v 1 can be expressed in tobacco plants. Since a
previous study on a bacterial-expressed recombinant Art v
1 demonstrated that some patient sera did not recognise the
bacterial recombinant Art v 1, we tested whether the plant
recombinant Art v 1 is recognised by IgE antibodies from
sera of allergic patients. The leaf lysate proteins from plant
no. 5 (Fig. 3) containing the plant recombinant Art v 1,
were separated by SDS-PAGE, blotted onto a nitrocellu-
lose membrane and tested for IgE binding (Fig. 4). In
contrast to sera of non-allergic patients (NHS, non-atopic
human sera), the various mugwort pollen-allergic patients’
sera contained IgEs against Art v 1 and recognised the
native, the bacterial recombinant and the plant recombinant
Art v 1 but no proteins in wild type tobacco plants except
patient nos. 9 and 22. Generally, the bacterial recombinant
Art v 1 was less recognised by the patients’ IgE than the
native Art v 1 and plant recombinant Art v 1 with the
exception of patient no. 75 who’s IgEs bound well to the
bacterial recombinant Art v1, too. Note that patient no. 11
although classiﬁed as mugwort pollen allergic by clinical
assays, did not recognise the mugwort pollen proteins.
Fig. 3 Stable expression of Art v 1 in leaves of transformed tobacco
plants. Transformed tobacco plants (Nicotiana tabacum) were gen-
erated by co-cultivation of leaf discs with Agrobacterium tumefaciens
containing the pBI121_Artv1 plasmid and regeneration in the
presence of kanamycin. Upper panel PCR with Art v 1-speciﬁc
primer resulted in a speciﬁc product of 620 bp in the control plasmid
(C, pBI121_Atrv1) and in plant nos. 1–5. An unspeciﬁc background
signal of 500 bp is detectable in transformants but also in PCR
experiments using DNA from wild-type tobacco. Lower panel
Immunodetection of recombinant Art v 1 in leaf lysates of
transformed tobacco plants 1–5. A typical double protein band of
20–25 kDa was detected by an anti Art v 1 antibody in the
transformants 1–5. Puriﬁed, native Art v1 (nArtv1) and a mugwort
pollen exudate (PE) served as positive controls. No protein signals
were observed in the leaf lysate of wild-type plants (WT). 25 lg
protein per lane. Plant no. 5 (in red) was used for further analysis
Fig. 4 Recognition of plant recombinant Art v 1 by allergenic patient
sera. Cell lysate proteins prepared from transformed plant no. 5 of
Fig. 3 (transformed, pBI121_Artv1) were separated by SDS-PAGE
and plant recombinant (plant rArtv1), bacteria recombinant (E.coli
rArtv1) and native Art v 1 (natArtv1), respectively, were detected by
Art v 1-speciﬁc IgEs from various patient sera as indicated by patient
numbers. No Art v 1-speciﬁc signals were detectable in wild type leaf
lysates or with a pool of non-atopic human sera (NHS). 25 lg protein
per lane. BC buffer control
566 Plant Cell Rep (2012) 31:561–571
123However, the IgEs of patient nos. 89 and 13 which
hardly bound to the bacterial recombinant Art v 1, recog-
nised the plant recombinant Art v 1 similar well as the
native Art v 1.
These promising results on the expression of Art v 1 that
is well recognised by patients’ sera, would make the
recombinant allergen an ideal tool in allergy diagnostic and
therapy. However, these experiments were performed with
transiently or stable transformed plants of the T0 generation.
Selection of transgenic plants in the following generations
resulted ﬁnally in a T3 generation with almost 100%
kanamycin resistance. Unfortunately, during the generation
cycles, the plants expressed less and less Art v 1 until it
became undetectable in plants of the T3 generation which
still grew on kanamycin (data not shown). In addition, the
transgenic plants grew slower and seemed to be more sen-
sitive against stress conditions. Since the physiological
function of Art v 1 has not been elucidated, one may assume
that its expression in plant tissues other than in the pollen
might affect its own production or genomic silencing of the
integrated transgene may have occurred. To minimise the
effects of Art v 1 on its own production, a new expression
strategy was designed in which the recombinant Art v 1 was
‘‘hidden’’ in the ER of the transgenic plants and a plant-
derived promoter was chosen.
Expression of ER-localised Art v 1 and GFP
The vector pBINPLUS/pIMPACT-Artv1
ER was con-
structed (Fig. 1) which (1) directs and retains the recom-
binant protein in the ER due to a signal peptide and a
C-terminal KDEL sequence, respectively, (2) allows the
detection and puriﬁcation via 6xHis and c-myc tags and
ﬁnally, (3) sets the expression under the control of the light-
regulated promoter of the small RuBisCO subunit 1 (rbcS1)
of Chrysanthemum morifolium Ramat. (Outchkourov et al.
2003). In parallel to transformation and expression of Art v
1, the same experiments were also performed with pBIN-
PLUS/pIMPACT-GFP
ER, in which the Art v 1 sequence has
been replaced by GFP to observe differences in the
expression of the two proteins and detect putative problems
with the expression of Art v 1. The strategy for the gener-
ation of Art v 1-expressing tobacco plants and cell cultures
starts with transient transformations of tobacco leaves by
injection of Agrobacteria to test the constructed plasmids,
the generation of stable transformed plants by leaf disc
regeneration and ﬁnally, the generation of transgenic cell
cultures from transformed tobacco plants of the T1 gener-
ation. All experimental steps were ﬁrst performed and
optimised with the GFP-expression plasmids because the
recombinant GFP could be detected not only via the fused
tags and a speciﬁc antibody but also by its own ﬂuores-
cence, and most importantly, its expression did not affect
the plant expression system as has been proven by a large
number of studies.
Pressure injection of Agrobacteria at the lower leaf side
led to a transient expression of GFP after 5 days (Fig. 5a).
Recombinant GFP was enriched by Ni–NTA agarose
afﬁnity chromatography and detected in the homogenate/
lysate (H) and the elution fractions (E1–E3). Furthermore,
GFP was still present in plants of the T1 generation, the
kanamycin-resistant offspring of the leaf disc-regenerated
T0-plantles (Fig. 5b). In every generation, the seeds from
GFP-expressing plants were collected, selected on kana-
mycin-containing media and growing plants were tested for
GFP. This time, GFP was still detectable in plants of the T3
generation: a leaf homogenate/lysate (H) was loaded onto a
Ni–NTA column and the ﬂow through (FT), washing
(W) and elution (E) fractions were analysed for GFP
(Fig. 5c). GFP could be detected indirectly by antibodies
against the His and c-myc tag, respectively, in the leaf
homogenates of transgenic but not of wild type plants.
Finally, the expression of GFP was directly observed in
mesophyll protoplasts prepared from leaves of a transgenic
plant (Fig. 5d). Bright ﬂuorescence signals are visible in
ER strands surrounding the nucleus and the chloroplasts.
This promising strategy was now applied to generate Art v
1-expressing plants. The transient transformations with the
constructed plasmid pBINPLUS/pIMPACT-Artv1
ER were
successful, too (data not shown). The recombinant Art v 1
could be detected in a number of transgenic plants of the T1
generation via the attached His or c-myc tag with no sig-
nals detectable in wild type lysates (Fig. 6). The signals
obtained by direct detection with the anti-Artv1 antibody
were too weak for documentation. The recombinant Art v 1
was also recognised by an anti-Artv1 antibody (data not
shown). These data indicate that the expression of the ER-
localised Art v 1 under the control of the RuBisCO pro-
moter was much more stable than that of the secreted
protein controlled by the CaMV 35 S promoter and yielded
detectable amounts of Art v 1 at least until the T1 gener-
ation. In this case, the targeting to the ER was probably the
more important parameter.
A cell culture was now generated from transgenic
tobacco plants with the aim to use the transgenic tobacco
cell culture for a stable and reliable production of recom-
binant Art v 1 in a closed fermenter system. Leaf discs of
surface-sterilised leaves from GFP- and Art v 1-expressing
plants (T1 generation) were incubated on Murashige and
Skoog medium supplemented with B5 vitamins, kanamy-
cin and 2,4-D in the dark at 24C. Visible calli were iso-
lated and cultivated on the same medium which was
changed every 2–3 weeks. Calli from both transgenic
plants were friable, showed a pale yellow colour when
cultivated in the dark and could be transferred to cell
suspension cultures. The expression of GFP and Art v1 in
Plant Cell Rep (2012) 31:561–571 567
123the respective calli grown in the dark, was very low and
almost at the detection limits (data not shown) due to the
light-regulated promoter. When calli were exposed to light,
they developed chloroplasts and turned green (Fig. S2).
Cell suspension cultures were generated from these calli
and grown at 16 h light/8 h dark cycles at 24C with
weekly sub-culturing. The recombinant proteins GFP and
Art v 1 could now be detected in these cultures (Fig. 7).
Crude cell homogenates/lysates were analysed by immu-
nodetection and antibodies against the protein itself and
against the fused tags recognised a protein band of the
appropriate molecular weight (Fig. 7a). In intact suspen-
sion cells, GFP ﬂuorescence was observed in the ER
around the nucleus (Fig. 7b).
Hence, these results provide a proof-of-principle for the
expression of the mugwort pollen allergen Art v 1 in plants.
But is this system suitable for a plant-based production of
recombinant Art v 1 to supply sufﬁcient amounts for
clinical allergy tests or even therapies? Unfortunately, the
answer at present is no due to several reasons. First, the
amounts of the recombinant allergen were very low. In
most experiments, no extra protein band not to mention a
prominent band was visible in Coomassie-stained protein
gels of all cell homogenates and the amount of 25 ml cell
culture was only sufﬁcient for detection. We estimate the
amount of recombinant Art v 1 as B1 lg per litre cell
culture which is far from a real overexpression (approxi-
mately 1 mg l
-1 cell culture) that might allow a proﬁtable
puriﬁcation of the protein. Second, the recombinant Art v 1
was retained in the ER thus making any puriﬁcation
laborious in comparison to secreted recombinant proteins
Fig. 5 GFP-expression in transformed tobacco plants. a Leaves of a
transformed tobacco plant (Agro-injection) were homogenised after
5 days, puriﬁed via Ni–NTA agarose and detected by an anti-GFP
antibody (H: 40 lg, E1–E3: 4 lg protein per lane). b Leaf homog-
enates of various stable transformed plants of the T1 generation
cultivated on kanamycin-containing media (numbers indicate indi-
vidual plants) and wild type (WT) were prepared and analysed by
immunodetection using an anti-His antibody (15 lg protein per lane).
c Detection of GFP in leaves harvested from tobacco plants of the T3
generation. GFP was puriﬁed from leaf homogenates by afﬁnity
chromatography (Ni–NTA IDA) and detected by an anti-GFP as well
as an anti-cmyc antibody directed against the C-terminal cmyc-tag
(27, 13, 6 and 1 lg protein per lane for fractions H, FT, W and E,
respectively). d Mesophyll protoplasts prepared from leaves of
transformed tobacco plant were observed by confocal laser scanning
microscopy. Bright ﬁeld image on the right and corresponding
ﬂuorescence image (left) Bar 10 lm. All plants were transformed
with pBINPLUSpIMPACT-GFP
ER. WT wild type homogenate,
H homogenate, FT ﬂow through of column, W wash fraction, E eluate
Fig. 6 Stable expression of ER-localised Art v 1 in tobacco plants.
Tobacco plants of the T1 generation were analysed by immunode-
tection of their respective tag (numbers indicate individual plants).
Recombinant Art v 1 was puriﬁed from leaf homogenates via afﬁnity
chromatography (Ni-IDA) and detected by antibodies directed to the
C-terminal tags, 6xHis and c-myc. 21 lg (WT) and 10 lg (transfor-
mants) protein per lane
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123even when up-scaling the cultures to litre volumes. It has to
be noted that tobacco plants and cell cultures expressing a
secreted form of Art v 1 and GFP were also generated but
preliminary experiments showed that the secreted recom-
binant proteins were hardly detectable in the cell culture
medium, even after including protein precipitation and
partial puriﬁcation steps.
The idea of producing proteins of plant origin in a plant
expression system seems intriguing especially for plant
allergens because plant-speciﬁc post-translational modiﬁ-
cations might contribute to the recognition by the human
immune system and therefore might be import for suc-
cessful therapies (Schmidt et al. 2008; Schmidt and Hoff-
man 2002; Singh and Bhalla 2006). Unfortunately, only a
few studies have been performed until today which suc-
ceeded in the expression of pollen allergens in plants (for
review see Schmidt et al. 2008). However, none of these
studies reported an overproduction of the recombinant
allergen that will facilitate the puriﬁcation and makes
plants or plant cell cultures an economical production
platform. Most of the plant allergens belong to families of
pathogenesis-related (PR) proteins (Hoffmann-Sommergr-
uber 2002; Radauer et al. 2008; Sels et al. 2008) which are
induced upon stress in plants. For instance, the latex
allergen Hev b 2, a 1,3 b-glucanase from Hevea brasili-
ensis, belongs to the PR-2 family and lipid transfer proteins
[e.g. Art v 3 (mugwort), Hev b 12 (rubber tree), Ole e 7
(olive)] belong to the PR-14 family. Expression of these
proteins and directing them to their site of action, the
‘‘external’’ cell wall, may trigger various processes in
plants during the stress response and therefore, an over-
expression of these proteins probably disturbs the normal
development and growth of the plant. Although, the
physiological function of Art v 1 is not known and its
expression and targeting to the cell wall is not lethal for
tobacco plants, the N-terminal defensin domain (Himly
et al. 2003) may ﬁnally disturb the normal growth and
expression pattern of the host plant although no phenotype
was observed under standard growth conditions. A similar
effect has been observed with the latex allergen Hev b 2
similar to tobacco 1,3 b-glucanases, which could be
expressed in tobacco plants only at a low amount (data not
shown). To circumvent any interference of plant allergen
proteins with the expression system, one might direct the
expression of the allergen protein to a very late state of
plant development, e.g. during the development of seeds or
fruits (Horvarth et al. 2000; Takaiwa et al. 2007). This
strategy has been tested for the expression of a peptide
constructed from cedar pollen allergen sequences, which
was then used for oral vaccination of mice (Takagi et al.
2005).
Despite the general application of molecular strategies
for the production of therapeutic proteins, the production of
plant-derived allergens might be particularly difﬁcult due
to the close relation between production system and
product.
Conclusion
The mugwort pollen allergen Art v 1 could be expressed in
plants and plant cell cultures using conventional Agro-
bacterium-mediated transformation methods. The expres-
sion was stable during a number of plant generations when
controlled by a light-regulated promoter and by targeting
the Art v 1 to the ER. Otherwise, the expression of Art v 1
was lost after a two generation cycles. So far, the amounts
of the recombinant protein were sufﬁcient for analysis but
would not meet the requirements for an economical
Fig. 7 Stable expression of ER-localised Art v 1 and GFP in cell
suspension cultures generated from transgenic tobacco plants. Cell
cultures were obtained from transformed tobacco plants via leaf disc
cultivation in the dark, selection with kanamycin and 2,4-D as
hormone. Calli were suspended in liquid media to obtain suspension
cultures and grown under artiﬁcial light. Cells were harvested for
analysing the recombinant proteins. a Cell homogenate analysed with
antibodies against the C-terminal tag and against the Art v 1 and GFP.
17 lg protein per lane. b Fluorescence image of a suspension cell
expressing GFP in the ER with the corresponding bright ﬁeld image.
Bar 20 lm
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123production of the recombinant allergen for clinical assays.
However, screening of much larger numbers of transgenic
plant lines ([1,000) might result in a plant line suitable for
economical production.
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